Aurore Perrot

Trials

Studies that name Aurore Perrot as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:11 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07284758 · A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  C4 Therapeutics, Inc. · recruiting · Multiple Myeloma, Relapsed/Refractory Multiple Myeloma · principal investigator
• Ph3
  NCT06918002 · Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients

  Intergroupe Francophone du Myelome · recruiting · Multiple Myeloma, Newly Diagnosed · principal investigator
• N/A
  NCT04888039 · Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"

  University Hospital, Toulouse · recruiting · Multiple Myeloma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.